Exosome hair loss marketing sits in a hard spot. Hair loss is a busy cash-pay service, and exosome copy follows the money. FDA exosome products for hair loss are not approved. That fact sets the limit on your page. Here is what a hair page can say, what it cannot, and how to fix it this week.
TLDR: No FDA approved exosome product exists. So FDA exosome products for hair loss are not approved. Your page can teach the science. It cannot promise regrowth or hint at approval. Photos count as claims. The before and after grid has to go. PRP sits in its own lane. Those kits are cleared for one narrow use. Hair work is off-label. The table below shows the swaps.
Important Note
This article is for educational purposes only and does not constitute legal, medical, or regulatory advice. Marketing strategies discussed should be reviewed by qualified legal counsel before implementation, particularly regarding FDA, FTC, and state-specific advertising regulations. Regen Portal is a marketing company, not a law firm or compliance consultancy. Nothing here implies FDA approval of any product or any use. The one exception is the narrow cord blood hematopoietic progenitor cell indication the FDA has actually licensed. Nothing here promises a marketing or business outcome. Regulations change and enforcement varies by state. Confirm current requirements with qualified legal and compliance counsel before you act on anything you read here.
Here is a pattern I have watched for years. A hair clinic adds an exosome page. The copy comes off a sales deck. A month later the page sells regrowth. The photo grid does the rest.
No one set out to break a rule. The words came from a vendor. The vendor was selling. Now the loosest page on the site sits on a service that pays.
You get the short version here. What the FDA has said. What a hair page may claim. How to fix the copy.
Why Exosome Hair Loss Pages Draw FDA Attention
Hair pages draw heat for one reason. They pair a product with a promised look. The Food and Drug Administration (FDA) has approved no exosome product for people. It handles them under its cell and gene therapy rules. Approval comes first.
Exosome hair loss marketing has a second problem. The photos claim what the words avoid. A before and after grid is still a claim.
The FDA put out its public safety notification on December 6, 2019. It says there are no approved exosome products. The consumer alert on exosomes says it in plain words. The Federal Trade Commission (FTC) adds the other half. Health claims need proof before you publish, not after.
So the page has one job.
What an Exosome Hair Loss Page Can and Cannot Say
Your page can say what an exosome is. It can say what research is looking at. It cannot claim regrowth or hint at approval. Describe the science, never the outcome.
PRP is the other half of most hair pages. The rule is different. Platelet-rich plasma (PRP) kits hold 510(k) clearance. That is a device clearance, not a drug approval.
The cleared use is preparing PRP to be mixed with bone graft material. Hair use is off-label. Say so. Label it. The full PRP marketing rules go deeper.
Exosome products have no cleared or approved lane. So the two cannot share one voice.
Here is compliant exosome language next to the copy that draws letters. The middle column is the delete list.
| Page Spot | Do Not Say | Compliant Version |
|---|---|---|
| Headline | Exosome hair regrowth therapy | Exosome research and hair loss |
| Product status | FDA approved exosome treatment | No approved exosome products exist |
| PRP block | Proven to regrow hair | PRP for hair is an off-label use |
| Photo grid | Before and after exosome results | Clinic and staff photos, no outcomes |
What this means for your practice: The right column is not weaker copy. It survives a review. It still answers what the reader came to ask. Our exosome rule set covers all channels.
Now for the rewrite.
How to Rewrite an Exosome Hair Loss Page This Week
Start with the headline, then the photos, then the button. Those three carry the risk. Body copy is the easy part.
Pull exosome wording out of the H1 and the meta title. Copy cannot upgrade what a product may be used for. That goes for headings and structured data too. FDA exosome guidance has not moved.
Then the photos. A before and after grid is the trap no one expects. The claim is visual. No one proofreads a photo.
Under an exosome heading, that grid is a claim. Keep result photos with services that can back them.
Last, the button. A booking button ties the product to a sale. The FDA reads that as marketing. Send the reader to a hair loss visit. Our guide to exosome service page structure covers the layout.
Five questions come up each time.
Frequently Asked Questions
Are Exosome Products FDA Approved for Hair Loss?
No. There are no FDA approved exosome products for any use in people. Hair loss is no exception. A page that says otherwise makes a claim the FDA answered.
What Can Clinics Legally Claim About Exosomes?
You may say what the product is. Research is fair game. So is calling the work early. Never promise a result, call it safe, or hint at approval.
What Is the FDA Public Safety Notification on Exosome Products?
It is the FDA statement of December 6, 2019. The notice says there are none. Use it when a vendor claims more.
How Should a Clinic Frame Exosome Hair Loss Content?
Teach it. Attach no offer. Explain the science, point to the FDA, and name what is unknown. Keep that block clear of any offer.
What Booking or Sales Language Must Be Avoided Entirely?
Anything that ties an exosome product to a sale. No booking button, no price, no package name, no waitlist. Those words turn a lesson into an ad.
Key Takeaways
- FDA exosome products for hair loss are not approved. No wording on the page changes that.
- Teach the science, name what is unknown, and keep result words out of the exosome block.
- PRP hair work is off-label use of a 510(k) cleared kit. Label it, and keep it apart.
- Photos and buttons make claims too. Audit the grid and the booking path.
Questions?
We treat Marketing Compliance as a service line, not a last checkbox. Most pages we review need edits, not a rebuild. If your site carries an exosome block, it has earned a second read. That is what Regen Portal does. Our compliance review starts here.
PS: Want the compliant exosome marketing checklist we run before a hair page goes live? Email me and I will send it over.
Email: hello@regenportal.com
YouTube: Subscribe to the channel
About Regen Portal
Regen Portal is a marketing company built for the regenerative medicine industry. We handle search engine optimization, content creation, social media management, paid advertising, website development, and branding for clinics, manufacturers, distributors, and independent providers. For more on me and how we work, visit Regen Portal and contact us.
About the Author
Oscar Tellez is the founder of Regen Portal, a marketing company built for the regenerative medicine industry. With over 15 years of experience spanning clinical operations, product distribution, and digital marketing, Oscar has helped hundreds of practices, manufacturers, and distributors grow through compliant, high-performance marketing strategies. He holds a B.S. in Exercise Physiology and Health Promotion from Florida Atlantic University.
